OFAC Adds Kaikai Technology to SDN List Over Synthetic Drug Trafficking
U.S. individuals and companies are now barred from dealing with Chinese-based Kaikai Technology after the Office of Foreign Assets Control on Oct. 15 put the company and owner Bo Peng, a Chinese national, on the Specially Designated Nationals list under…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
authorities provided by the Kingpin Act, the agency said (here). OFAC labeled Kaikai a “purported pharmaceutical and chemical products company” that has exported large amounts of synthetic drugs, including stimulants and marijuana. A grand jury in a Florida district court indicted Peng on charges of “importing and conspiring to import ethylone and the Schedule I controlled substance methylone,” said OFAC. The OFAC action freezes all Kaikai and Peng assets in the U.S.